Skip to content
Review Open access

Association between atherogenic dyslipidemia and DBS-derived p-tau217 in older adults: evidence from SHARE DBS data

Sep 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 36 references
Medicine

Abstract

Background Atherogenic dyslipidemia has been associated with adverse cognitive and dementia-related outcomes, but its relationship with Alzheimer’s disease-related blood biomarkers remains unclear. Objective To examine whether the atherogenic index of plasma (AIP) is associated with dried blood spot (DBS)-derived phosphorylated tau 217 (p-tau217) in older adults from Germany, Sweden, and Denmark. Materials and methods This cross-sectional analysis included adults aged ≥50 years from Germany, Sweden, and Denmark in the Survey of Health, Ageing and Retirement in Europe DBS biomarker substudy. AIP was calculated as log10(triglycerides/high-density lipoprotein cholesterol). Multivariable linear regression with robust standard errors evaluated standardized natural log-transformed p-tau217, with additional dose–response analyses, comparisons across neurological biomarkers, and sensitivity analyses. Results Among 2,676 participants, a 1-SD higher AIP was associated with a 0.074-SD higher ln(p-tau217) (95% CI, 0.034–0.115; p < 0.001), corresponding after back-transformation to a 5.2% higher adjusted geometric mean DBS-derived p-tau217 concentration (95% CI, 2.3–8.1%). The highest versus lowest AIP quartile was associated with higher p-tau217 (β, 0.162; 95% CI, 0.052–0.272; p = 0.004), although estimates across quartiles were not strictly monotonic. Associations were statistically supported for p-tau217 and total tau, but not for GFAP or NfL after FDR correction. Results were robust in sensitivity analyses. Conclusion In this cross-sectional analysis, higher AIP, reflecting atherogenic dyslipidemia, was associated with a modestly higher DBS-derived p-tau217 concentration in older adults. The biological and clinical significance of this association remains to be established in longitudinal and multimodal studies.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.